References
- March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (Oxford, England) 2010;25:544–51
- Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011;95:1073–9
- Franks S, Stark J, Hardy K. Follicle dynamics and an ovulation in polycystic ovary syndrome. Hum Reprod Update (Oxford, England) 2008;14:367–78
- Norman RJ, Noakes M, Wu R, et al. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update (Oxford, England) 2004;10:267–80
- Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011;7:CD007506
- American Society for Reproductive Medicine, Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in women. Fertil Steril 2003;5:1303–8
- Randall JM, Templeton A. Transvaginal sonographic assessment of follicular and end endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril 1991;56:208–12
- PCOS consensus. The Thessaloniki ESHRE/ASRM-Sponsored PCOS consensus workshop group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008;89:505–22
- Homburg R. Clomiphene citrate – end of an era? A mini-review. Hum Reprod (Oxford, England) 2005;20:2043–51
- Opsahl MS, Robins ED, O'Connor DM, et al. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996;66:533–9
- PCOS consensus. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
- Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update (Oxford, England) 2010;16:231–45
- Chung H, Craig AW. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril 1989;52:564–8
- Dehbashi S, Vafaei H, Parsanezhad MD, Alborzi S. Time of initiation of clomiphene citrate and pregnancy rate in polycystic syndrome. Int J Gynaecol Obstet: Official Org Int Federat Gynaecol Obstet 2006;93:44–8
- Palatnik A, Strawn E, Szabo A, Robb P. What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. Fertil Steril 2012;97:1089–94 e1-3
- Shalom-Paz E, Marzal A, Wiser A, et al. Does optimal follicular size in IUI cycles vary between clomiphene citrate and gonadotropins treatments? Gynecol Endocrinol: Official J Int Soc Gynecol Endocrinol 2014;30:107–10
- Rosen MP, Shen S, Dobson AT, et al. A quantitative assessment of follicle size on oocyte developmental competence. Fertil Steril 2008;90:684–90
- Agarwal SK, Buyalos RP. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Hum Reprod (Oxford, England) 1995;10:328–31
- Farhi J, Orvieto R, Gavish O, Homburg R. The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients. Gynecol Endocrinol: Official J Int Soc Gynecol Endocrinol 2010;26:546–8
- Haritha S, Rajagopalan G. Follicular growth, endometrial thickness, and serum estradiol levels in spontaneous and clomiphene citrate-induced cycles. Int J Gynaecol Obstet: Official Org Int Federat Gynaecol Obstet 2003;81:287–92
- Legro RS, Barnhart HX, Schlaff WD, et al. Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551–66
- Konig T, Homburg R, Hendriks ML, et al. Do monitoring and hCG administration influences the outcome of clomiphene treatment for anovulatory PCOS? Hum Reprod (Oxford, England) 2009;24:35–6
- Yilmaz B, Kelekci S, Savan K, et al. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function. Fertil Steril 2006;85:783–6